Derivation of endothelial cells from porcine induced pluripotent stem cells by optimized single layer culture system.
Renyue WeiJiawei LvXuechun LiYan LiQianqian XuJun-Xue JinYu ZhangZhong-Hua LiuPublished in: Journal of veterinary science (2020)
Regenerative therapy holds great promise in the development of cures of some untreatable diseases such as cardiovascular diseases, and pluripotent stem cells (PSCs) including induced PSCs (iPSCs) are the most important regenerative seed cells. Recently, differentiation of human PSCs into functional tissues and cells in vitro has been widely reported. However, although porcine reports are rare they are quite essential, as the pig is an important animal model for the in vitro generation of human organs. In this study, we reprogramed porcine embryonic fibroblasts into porcine iPSCs (piPSCs), and differentiated them into cluster of differentiation 31 (CD31)-positive endothelial cells (ECs) (piPSC-derived ECs, piPS-ECs) using an optimized single-layer culture method. During differentiation, we observed that a combination of GSK3β inhibitor (CHIR99021) and bone morphogenetic protein 4 (BMP4) promoted mesodermal differentiation, resulting in higher proportions of CD31-positive cells than those from separate CHIR99021 or BMP4 treatment. Importantly, the piPS-ECs showed comparable morphological and functional properties to immortalized porcine aortic ECs, which are capable of taking up low-density lipoprotein and forming network structures on Matrigel. Our study, which is the first trial on a species other than human and mouse, has provided an optimized single-layer culture method for obtaining ECs from porcine PSCs. Our approach can be beneficial when evaluating autologous EC transplantation in pig models.
Keyphrases
- endothelial cells
- induced pluripotent stem cells
- pluripotent stem cells
- high glucose
- induced apoptosis
- mesenchymal stem cells
- cell cycle arrest
- stem cells
- cell therapy
- cardiovascular disease
- signaling pathway
- endoplasmic reticulum stress
- vascular endothelial growth factor
- clinical trial
- left ventricular
- type diabetes
- gene expression
- pi k akt
- cell death
- study protocol
- bone marrow
- aortic valve
- randomized controlled trial
- cell proliferation
- atrial fibrillation
- pulmonary hypertension
- artificial intelligence
- phase iii
- phase ii
- genetic diversity
- cardiovascular events
- placebo controlled